GS
JAZZ icon

GAM Systematic’s Jazz Pharmaceuticals JAZZ Stock Holding History

GAM Systematic’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$529K Buy
+3,618
New +$547K 0.08% 402

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

GAM Systematic's JAZZ Position: Q3 2017 in Review

GAM Systematic opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2017: 3,618 shares worth $529K. The stake represents 0.08% of the portfolio and ranks #402 among its holdings.

303 funds tracked by Wall St. Rank hold JAZZ as of Q3 2017.

  • GAM Systematic held 3,618 shares of Jazz Pharmaceuticals worth $529K as of Q3 2017.
  • Jazz Pharmaceuticals was a new GAM Systematic position in Q3 2017.
  • Jazz Pharmaceuticals made up 0.08% of GAM Systematic's portfolio in Q3 2017, its #402 holding.
  • 303 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.